Dr. Reddys to acquire 8 ANDAs for $350 million – Aims to become relevant in the US
Dr. Reddys Laboratories has entered into a definitive agreement with Teva Pharmaceutical Industries Ltd and an affiliate of Allergan plc […]
Say something
Dr Reddys receives USFDA approval for injection for treating migraines
The US Food and Drug Administration (FDA) has approved Dr Reddy’s ZEMBRACEâ„¢SymTouchâ„¢ (sumatriptan succinate) injection, a drug-device combination product intended […]
Dr Reddy’s Buy IP Rights for Anti-Coagulant Drug
Dr Reddy’s Laboratories and Australian drug discovery and development company Alchemia have entered into a $17.5 million agreement for anti-coagulant […]
Dr Reddys Inks commercialisation Deal with Hatchtech
Dr Reddy’s Laboratories has announced the signing of a commercialisation deal with Hatchtech, an Australian pharmaceutical company for developing an […]
Dr Reddys Announces Strategic Collaboration with Amgen in India
Dr Reddys Laboratories has entered into a strategic collaboration with Amgen to market and distribute three Amgen medicines in India […]
Dr. Reddy announces Filing of Annual Report on Form 20-F
Dr. Reddys Laboratories Limited, an integrated pharmaceutical company, has announced that its Annual Report on Form 20-F, containing its annual […]
Dr Reddys, AstraZeneca Inks Agreement for Saxagliptin
Dr Reddys Laboratories Limited and AstraZeneca Pharma India Limited (AZPIL) signed a distribution agreement for Riax, a new brand of […]
-
-
Flipkart Health+ App Launched
06-04-2022
